1 / 4

Christoph Schramm, Ansgar W. Lohse I. Medizinische Klinik und Poliklinik

Immunosuppression and PSC. Christoph Schramm, Ansgar W. Lohse I. Medizinische Klinik und Poliklinik Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany. Immunosuppression and PSC - background.

stella-finch
Download Presentation

Christoph Schramm, Ansgar W. Lohse I. Medizinische Klinik und Poliklinik

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immunosuppression and PSC Christoph Schramm, Ansgar W. Lohse I. Medizinische Klinik und Poliklinik Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany

  2. Immunosuppression and PSC - background • Up to 10 % of PSC patients have overlapping features with autoimmune hepatitis (secondary AIH) • Patients with features of autoimmune hepatitis benefit from immunosuppressive treatment • A potential benefit of immunosuppression on early stages of PSC is unknown

  3. Hypothesis • Patients with an inflammatory type of PSC / secondary autoimmune hepatitis benefit from immunosuppression with prednisolone/azathioprine

  4. Study Group project • Retrospective study: • Collect data on patients with PSC who received immunosuppression not related to IBD • Compare long term survival/Ltx to matched control population without immunosuppression • Prospective study: • Define criteria for immunosuppression in PSC, e.g. ALT > 3x ULN, IgG > 1,2x ULN, histology with mHAI > 6, Scheuer > 2 (portal/periportal activity) • Prospectively collect data

More Related